China National Accord Medicines Corporation Ltd.

Equities

000028

CNE0000009N6

Pharmaceuticals

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
35.11 CNY -2.42% Intraday chart for China National Accord Medicines Corporation Ltd. -0.31% +21.11%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
China National Accord Medicines Corporation Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
China National Accord Medicines Corporation Ltd. Proposes Final Cash Dividend for the Year 2023 CI
China National Accord Medicines Corporation Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
China National Accord Medicines' Profit Slides 4% in Q3 MT
China National Accord Medicines Corporation Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
China National Accord Medicines Corporation Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Correction: Sinopharm Subsidiary Sinopharm Accord Logs Over 29% Jump in H1 Net Profit MT
Sinopharm Group Logs Over 29% Jump in H1 Net Profit MT
China National Accord Medicines Approves Final Cash Dividend for 2022 CI
Energy International Investments to Raise HK$150 Million from Share Issue to Affiliate MT
Sinopharm Accord Logs 44% Rise in Q1 Profit MT
Sinopharm Accord's Q1 Profit Surges 43.5% MT
China National Accord Medicines Corporation Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
China National Accord Medicines Corporation Ltd. Proposes Final Cash Dividend for the Year 2022 CI
Pfizer signs strategic cooperation pact with China's Sinopharm RE
Sinopharm Accord's 2022 Attributable Profit Up 11%; Shares Jump 5% MT
China National Accord Medicines Corporation Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
China National Accord Medicines Corporation Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Merck's COVID treatment expected to launch in China on Friday RE
China National Accord Medicines Corporation Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
China National Accord Medicines Corporation Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
China National Accord Medicines Corporation Ltd. Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on June 17, 2022 CI
China National Accord Medicines Corporation Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
China National Accord Medicines Corporation Ltd. Approves Final Cash Dividend for the Year 2021 CI
Nomura Adjusts China National Accord Medicines' Price Target to 49.1 Yuan From 54.5 Yuan, Keeps at Buy MT
Chart China National Accord Medicines Corporation Ltd.
More charts
China National Accord Medicines Corporation Ltd. is a China-based company principally engaged in the pharmaceutical wholesaling, retailing and manufacturing businesses. The Company's main products include antibiotic preparations, power injections, antibiotic Active Pharmaceutical Ingredients (APIs), respiratory system drugs and cardiovascular and cerebrovascular system drugs, among others. The Company is also involved in the provision of logistics and storage services, leasing services and training services, among others. The Company distributes its products mainly in domestic market.
Calendar
More about the company
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
35.11 CNY
Average target price
37.97 CNY
Spread / Average Target
+8.15%
Consensus